Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>We recently visited Guangzhou city, a tier one city in China, on a vacation trip. </li>
<li>One of the malls that we visited happened to have several listed tea chain stores.</li>
<li>We took a snapshot of the shop traffic and noted the difference in locations of various stores. We also ordered tea drinks from two of these stores.</li>
</ul>


We recently visited Guangzhou city, a tier one city in China, on a vacation trip. 
One of the malls that we visited happened to have several listed tea chain stores.
We took a snapshot of the shop traffic and noted the difference in locations of various stores. We also ordered tea drinks from two of these stores.


Sichuan Baicha Baidao Industrial (2555 HK)

Chinese Tea Chain: An Impromptu Snapshot Visit at Sunac Mall - Mixue, Chagee, Goodme, ChaPanda

Chagee Holdings

Chinese Tea Chain: An Impromptu Snapshot Visit at Sunac Mall - Mixue, Chagee, Goodme, ChaPanda